NCT04665570
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Many locations Multiple Locations, India
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,045 public trials
714 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT05781334
- Conditions
- Cardiovascular Diseases, Chronic Disease, Chronic Kidney Diseases, +20 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT05227196
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Altasciences Clinical LA, Inc. Cypress, California, United States
- Altasciences Clinical Kansas, Inc. Overland Park, Kansas, United States
- Altasciences Company Inc. Montreal, Quebec, Canada
NCT05465317
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Duke Clinical Research Institute Durham, North Carolina, United States
NCT03939624
- Conditions
- All-Cause Mortality, Brain Diseases, Cardiovascular Death, +23 more
- Locations
-
- Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada
NCT04537624
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Master Centre Switzerland Zurich, Oerlikon, Switzerland
NCT06586775
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Dr.keerthana Rohtak, Haryana, India
Completed
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
NCT04109547
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Bouzareah Diabetic House Algiers Algeria Algiers, Algeria
- UH of Douera Algiers, Algeria
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Beijing Pinggu Hospital Beijing, Beijing Municipality, China
Completed
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
NCT04017221
- Conditions
- Acid-Base Imbalance, Acidosis, Diabetes Complications, +10 more
- Locations
-
- Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada
NCT02800668
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
- Locations
-
- Herz- und Diabeteszentrum Bad Oeynhausen, Germany